04 Apr 2023 Wellbeing

£200 grants for people affected by leukaemia once again available

Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), whose lives have been impacted by the ongoing cost of living crisis. 

Applications are open now for grants of up to £200 provided by the Leukaemia UK and Leukaemia Care ‘Cost of Living Fund’. Over £168,000 was given to families affected by leukaemia, MDS or an MPN in 2022. Together, Leukaemia UK and Leukaemia Care hope that the relaunch of this fund will provide much-needed support during one of the most difficult times of a person’s life. 

Fiona Hazell, Chief Executive of Leukaemia UK, said: 

“The relaunch of the Cost of Living with Leukaemia Fund will help to improve the lives of more people across the UK living with leukaemia. The emotional and physical challenges of leukaemia are profound, and the diagnosis often brings additional financial pressures during what is already one of the most difficult times of a person’s life. The Cost of Living with Leukaemia Fund will make a tangible difference to their lives, and we are very grateful to our supporters for making this relaunch possible.” 

Please visit the Leukaemia Care website to find out more. 

Related posts

Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy

31 October 2022

Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy

Blood cancer research charity, Leukaemia UK, has hired Anna Wilson and Lizzie Afonso from housing and homelessness charity, Shelter, to job-share its new Communications Director role. This is the first…

Leukaemia UK announces innovative projects by four female researchers addressing aggressive blood cancers

23 October 2024

Leukaemia UK announces innovative projects by four female researchers addressing aggressive blood cancers

Leukaemia UK has today announced it will invest £600,000 into four groundbreaking research projects aimed at developing kinder, more effective treatments for various aggressive blood cancers, including acute myeloid leukaemia…

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

8 July 2025

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

The Best Practice Timed Pathway We’re delighted to share that Leukaemia UK, in partnership with Lymphoma Action and Myeloma UK, is working with the NHS England Cancer programme team to…

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…